Fundraising Fox

Capital Rx, Inc.

New York, US · 10 known investors

Founders & leadership

RK
Ryan KellyCo-founder
AJ
A. J. LoiaconoCo-founder

Board

LM
Lenard MarcusBoard director
JK
Jared KesselheimBoard director
KH
Kevin HillBoard director
RM
Robert MittendorffBoard director
DD
Daniel DelmastroBoard director
FA
Feby AbrahamBoard director

Investors · 10

9Yards CapitalreportedNew York · $100K – $10M
B CapitalreportedGeneva
B4 Capitalreported$10M – $50Mvia Robert Mittendorff · board
Edison Partnersreported · 2 sourcesNashville · $5M – $25Mvia Lenard Marcus · board
General Catalystreported · 2 sourcesSan Francisco · $30Mvia Holly Maloney · board
Generation Investment ManagementreportedLondon
TRANSFORMATION CAPITALreported · 2 sourcesBoston
Wellington ManagementreportedBoston · $5M – $50M

Also in the syndicate · 2

Growth Equity at Goldman Sachs AlternativesPrime Health Investments

Reported raises · per SEC filings

Form D private placements

$499.6M disclosed across 6 rounds · 2019–2025

▶$230.8MraisedSep 2025 · 8 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jared KesselheimDirector
  • Mark KandrysawtzDirector
  • Lenard MarcusDirector
  • Ryan KellyDirector
  • Robert MittendorffDirector
  • Kevin HillDirector
  • Holly MaloneyDirector
  • Mostafa KamalDirector
  • A. J. LoiaconoExecutive Officer, Director
  • Daniel DelmastroDirector
Offering amount
$232.9M
Amount sold
$230.8M
First sale
Aug 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$115MraisedMar 2024 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Lenard MarcusDirector
  • Jared KesselheimDirector
  • Ryan KellyDirector
  • Kevin HillDirector
  • A. J. LoiaconoDirector, Executive Officer
  • Robert MittendorffDirector
  • Feby AbrahamDirector
  • Daniel DelmastroDirector
Offering amount
$312.5M
Amount sold
$115M
First sale
Mar 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$106MraisedJun 2022 · 9 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Jared KesselheimDirector
  • Laleh AlemzadehExecutive Officer
  • Ryan KellyDirector
  • Robert MittendorffDirector
  • Joseph AlexanderExecutive Officer
  • Kevin HillDirector
  • A. J. LoiaconoExecutive Officer, Director
  • Lenard MarcusDirector
Offering amount
$106M
Amount sold
$106M
First sale
May 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3.5MraisedJul 2021 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan KellyDirector
  • Joseph AlexanderExecutive Officer, Director
  • Lenard MarcusDirector
  • A. J. LoiaconoExecutive Officer, Director
  • Kevin HillDirector
  • Jared KesselheimDirector
  • Laleh AlemzadehExecutive Officer
Offering amount
$3.5M
Amount sold
$3.5M
First sale
Apr 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$32MraisedJan 2021 · 4 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Ryan KellyDirector
  • A. J. LoiaconoExecutive Officer, Director
  • Lenard MarcusDirector
  • Laura AlemzadehExecutive Officer
  • Kevin HillDirector
  • Jared KesselheimDirector
  • Joseph AlexanderExecutive Officer, Director
Offering amount
$53M
Amount sold
$32M
First sale
Dec 2020
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.4MraisedJul 2019 · 1 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • A.J. LoiaconoExecutive Officer, Director
  • Ryan KellyDirector
  • Joseph AlexanderDirector
  • Lenard MarcusDirector
Offering amount
$16.4M
Amount sold
$12.4M
Minimum investment
$16.4M
First sale
Jul 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Capital Rx Announces Funding Round of $400M to Accelerate AI-Powered Health Benefits Platform; Rebrands as "Judi Health" to Reflect Expansion Beyond Pharmacyprnewswire.com · Sep 2025

Frequently asked questions

Who founded Capital Rx, Inc.?
Capital Rx, Inc. was founded by Ryan Kelly, A. J. Loiacono.
Who are Capital Rx, Inc.'s investors?
Capital Rx, Inc.'s investors include 9Yards Capital, B Capital, B4 Capital, Edison Partners, General Catalyst, Generation Investment Management, TRANSFORMATION CAPITAL, Wellington Management.
How much funding has Capital Rx, Inc. raised?
Capital Rx, Inc. has disclosed $499.6M raised across 6 rounds.
Where is Capital Rx, Inc. headquartered?
Capital Rx, Inc. is headquartered in New York, US.